Department of Internal Medicine I, Klinikum Augsburg, Ludwig Maximilians University of Munich, Munich, Germany.
BMC Pulm Med. 2012 Jun 7;12:23. doi: 10.1186/1471-2466-12-23.
Increased ventilatory response has been shown to have a high prognostic value in patients with chronic heart failure. Our aim was therefore to determine the ventilatory efficiency in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension by cardiopulmonary exercise testing (CPET) identifying PH-patients with increased risk for death within 24 months after evaluation.
116 patients (age: 64 ± 1 years) with a mean pulmonary arterial pressure of 35 ± 1 mmHg underwent CPET and right heart catheterization. During a follow-up of 24 months, we compared the initial characteristics of survivors (n = 87) with nonsurvivors (n = 29).
Significant differences (p ≤ 0.005) between survivors and nonsurvivors existed in ventilatory equivalents for oxygen (42.1 ± 2.1 versus 56.9 ± 2.6) and for carbon dioxide (Ve/VCO2) (47.5 ± 2.2 versus 64.4 ± 2.3). Patients with peak oxygen uptake ≤ 10.4 ml/min/kg had a 1.5-fold, Ve/VCO2 ≥ 55 a 7.8-fold, alveolar-arterial oxygen difference ≥ 55 mmHg a 2.9-fold, and with Ve/VCO2 slope ≥ 60 a 5.8-fold increased risk of mortality in the next 24 months.
Our results demonstrate that abnormalities in exercise ventilation powerfully predict outcomes in PH. Consideration should be given to add clinical guidelines to reflect the prognostic importance of ventilatory efficiency parameters in addition to peak VO2.
已经证明,慢性心力衰竭患者的通气反应增加具有很高的预后价值。因此,我们的目的是通过心肺运动测试(CPET)确定肺动脉高压和慢性血栓栓塞性肺动脉高压的通气效率,确定在评估后 24 个月内死亡风险增加的 PH 患者。
116 名平均肺动脉压为 35 ± 1 mmHg 的患者接受了 CPET 和右心导管检查。在 24 个月的随访中,我们比较了幸存者(n = 87)和非幸存者(n = 29)的初始特征。
幸存者和非幸存者之间存在显著差异(p ≤ 0.005),包括氧通气当量(42.1 ± 2.1 与 56.9 ± 2.6)和二氧化碳通气当量(Ve/VCO2)(47.5 ± 2.2 与 64.4 ± 2.3)。峰值摄氧量≤10.4 ml/min/kg 的患者,Ve/VCO2≥55 的患者,肺泡-动脉氧差≥55 mmHg 的患者,以及 Ve/VCO2斜率≥60 的患者,在接下来的 24 个月内死亡的风险分别增加 1.5 倍、7.8 倍、2.9 倍和 5.8 倍。
我们的结果表明,运动时通气异常有力地预测 PH 的结局。在制定临床指南时,应考虑除了峰值 VO2 之外,增加通气效率参数的预后重要性。